Print

Print


Update on surgery for Parkinson's disease.

Movement disorders
Current Opinion in Neurology. 20(4):465-469, August 2007.
Volkmann, Jens
Abstract:
Purpose of review: The clinical effectiveness and limitations of subthalamic
nucleus deep brain stimulation for Parkinson's disease are summarized and
recent developments concerning alternative brain targets for deep brain
stimulation or restorative surgical therapies are discussed.
Recent findings: In a controlled study subthalamic nucleus deep brain
stimulation was superior to best medical management in improving quality of
life of patients with advanced Parkinson's disease. The benefits of the
procedure on levodopa-sensitive motor symptoms are sustained for up to 5
years, but it does not halt disease progression. Cognitive decline and
worsening of axial motor symptoms may limit the overall benefit. Age at the
time of surgery is an important factor for long-term stability and safety.
Psychosocial aspects of Parkinson's disease can profoundly impact on the
ability of a patient to reintegrate after surgery and have to be considered
in patient selection. Stimulation of the pedunculopontine nucleus may have
an additive effect on postural and gait symptoms, which do not respond to
levodopa or subthalamic nucleus deep brain stimulation.
Summary: Deep brain stimulation is emerging from an empirical to an evidence
based therapy. The safety and efficacy of the procedure may legitimize
surgery at a younger age before social maladjustment prevents reintegration
of the patient into a normal life.
(C) 2007 Lippincott Williams & Wilkins, Inc.

Rayilyn Brown
Board Member AZNPF
Arizona Chapter National Parkinson's Foundation
[log in to unmask]

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn